您的位置: 首页 > 农业专利 > 详情页

Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors
专利权人:
Inc.;BioMed Valley Discoveries
发明人:
Saha, Saurabh,Welsch, Dean,Decrescenzo, Gary,Roix, Jeffrey James
申请号:
AU2014368916
公开号:
AU2014368916A1
申请日:
2014.12.19
申请国别(地区):
AU
年份:
2016
代理人:
摘要:
The present invention provides, inter alia, methods, kits, and compositions for treating or ameliorating the effects of a cancer in a subject in need thereof. This method includes administering to the subject an effective amount of (i) a first anti-cancer agent, which is BVD-523 or a pharmaceutically acceptable salt thereof and (ii) a second anti-cancer agent, which is an inhibitor of the PI3K/Akt pathway or a pharmaceutically acceptable salt thereof. Also provided are methods of treating or ameliorating the effects of a subject with cancer in which the subject has a somatic KRAS and a somatic PIK3CA mutation or in which the cancer is refractory to a therapy selected from RAF inhibitor therapy, MEK inhibitor therapy, and RAF and MEK inhibitor therapy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充